Evidence map›Paper›PMID 37045850›Full record

ArticleScientific reports2023

Application of Mendelian randomization to explore the causal role of the human gut microbiome in colorectal cancer.

Charlie Hatcher, George Richenberg, Samuel Waterson, Long H Nguyen, Amit D Joshi, Robert Carreras-Torres, Victor Moreno, Andrew T Chan, Marc Gunter, Yi Lin and 17 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 15 institutions in 7 countries.

Charlie Hatcher *MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK.
George Richenberg *MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK.
Samuel WatersonPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS8 2BN, UK.
Long H NguyenMassachusetts General Hospital, Boston, MA, 02114, USA.
Amit D JoshiMassachusetts General Hospital, Boston, MA, 02114, USA.
Robert Carreras-TorresColorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Barcelona, Spain.
Victor MorenoColorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Barcelona, Spain.
Andrew T ChanMassachusetts General Hospital, Boston, MA, 02114, USA.
Marc GunterInternational Agency for Research on Cancer, 150 Cours Albert Thomas, 69372, Lyon, CEDEX 08, France.
Yi LinFred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Seattle, WA, 98109, USA.
Conghui QuPublic Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Mingyang SongDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA.
Graham CaseyCenter for Public Health Genomics, University of Virginia, Charlottesville, VA, USA.
Jane C FigueiredoDepartment of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Stephen B GruberDepartment of Preventive Medicine, USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Jochen HampeDepartment of Medicine I, University Hospital Dresden, Technische Universität Dresden (TU Dresden), Dresden, Germany.
Heather HampelDivision of Human Genetics, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Mark A JenkinsCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
Temitope O KekuCenter for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, NC, USA.
Ulrike PetersPublic Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Catherine M TangenSWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Anna H WuPreventative Medicine, University of Southern California, Los Angeles, CA, USA.
David A HughesMRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK.
Malte C RühlemannInstitute of Clinical Molecular Biology, Christian Albrechts University of Kiel, Kiel, Germany.
Jeroen RaesDepartment of Microbiology and Immunology, Rega Instituut, KU Leuven, University of Leuven, Leuven, Belgium.
Nicholas J TimpsonMRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK.
Kaitlin H WadeMRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK. Kaitlin.Wade@bristol.ac.uk.
University of Bristol · GBFred Hutch Cancer Center · USMassachusetts General Hospital · USUniversity of Southern California · USBellvitge University Hospital · ESCedars-Sinai Medical Center · USCentre for Biomedical Network Research on Rare Diseases · ESCentre International de Recherche sur le Cancer · FRKiel University · DEThe Ohio State University · USTU Dresden · DEUniversity of Melbourne · AUUniversity of North Carolina at Chapel Hill · USUniversity of Virginia · USVIB-KU Leuven Center for Microbiology · BE

Funding

SWOG NCORP Research BaseUG1CA189974 · NCI · THE HOPE FOUNDATION · PI CHARLES D. BLANKE, DAWN HERSHMAN · 2014 to 2026
$80.6M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3M
PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer ResearchU01CA182883 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI TANGEN, CATHERINE M., THOMPSON, IAN M. · 2019 to 2023
$5.4M
Coffee and metabolites modulating the gut microbiome for improved colorectal cancer survivalR01CA263776 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Mingyang Song · 2022 to 2026
$3.3M
The Gut Microbiome, Lifestyle, and Colorectal NeoplasiaU01CA261961 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Mingyang Song · 2022 to 2026
$3.0M
Cancer Research UK 29019Cancer Research UK C18281/A29019Cancer Research UK RCCPDF\100007Department of Health BRC-1215-2001Medical Research Council MC_UU_00011/1NCI NIH HHS R01 CA263776NCI NIH HHS U01 CA182883NCI NIH HHS U01 CA261961NCI NIH HHS UG1 CA189974NIEHS NIH HHS P30 ES010126Wellcome TrustWellcome Trust 202802/Z/16/ZWellcome Trust 217065/Z/19/ZWorld Health Organization 001
6 · The paper itself

Abstract

The role of the human gut microbiome in colorectal cancer (CRC) is unclear as most studies on the topic are unable to discern correlation from causation. We apply two-sample Mendelian randomization (MR) to estimate the causal relationship between the gut microbiome and CRC. We used summary-level data from independent genome-wide association studies to estimate the causal effect of 14 microbial traits (n = 3890 individuals) on overall CRC (55,168 cases, 65,160 controls) and site-specific CRC risk, conducting several sensitivity analyses to understand the nature of results. Initial MR analysis suggested that a higher abundance of Bifidobacterium and presence of an unclassified group of bacteria within the Bacteroidales order in the gut increased overall and site-specific CRC risk. However, sensitivity analyses suggested that instruments used to estimate relationships were likely complex and involved in many potential horizontal pleiotropic pathways, demonstrating that caution is needed when interpreting MR analyses with gut microbiome exposures. In assessing reverse causality, we did not find strong evidence that CRC causally affected these microbial traits. Whilst our study initially identified potential causal roles for two microbial traits in CRC, importantly, further exploration of these relationships highlighted that these were unlikely to reflect causality.

Indexed as

Colorectal NeoplasmsGastrointestinal MicrobiomeCausalityGenome-Wide Association StudyHumansMendelian Randomization AnalysisPolymorphism, Single Nucleotide

Identifiers

PMID37045850
PMCPMC10097673
OpenAlexW4365141750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.